Literature DB >> 16338034

The matrix metalloproteinase system in oral squamous cell carcinoma.

E A Baker1, D J Leaper, J P Hayter, A J Dickenson.   

Abstract

BACKGROUND: The matrix metalloproteinase (MMP) system is responsible for degradation of tissue in both normal and pathological processes, including tumour invasion and metastasis. AIM: To compare tissue concentrations of components of the MMP system between tumour tissue and normal tissue in patients with oral squamous cell carcinoma, and to correlate concentrations with pathological grade of tumour.
METHODS: Thirty-eight paired tissue samples from tumours and normal tissue were analysed by three laboratory techniques: firstly, enzyme linked immunosorbent assays (ELISA) in ng/mg protein for MMP-1, MMP-3, and tissue inhibitors of metalloproteinases (TIMPs) -1 and -2. Secondly, gelatinase activity assays to measure concentrations of total and endogenous active gelatinases, MMP-2 and MMP-9 (ng/mg protein). And thirdly to use quenched fluorescent substrate hydrolysis to measure total MMP activity (pM/min).
RESULTS: The concentration of all MMPs was significantly higher in tumour than in normal oral tissue (p < 0.05, Mann-Whitney U-test). Tissue concentrations of some of these factors correlated with clinical and pathological indices of aggressiveness of tumours, including T-stage, N-stage, tumour differentiation, and anatomical level of involved nodes. However, the study was not powered to show statistical significance.
CONCLUSION: It is the balance between proteinases and their inhibitors that controls tissue degradation at each stage of tumour invasion and metastasis. Measurement of MMPs in oral mucosal biopsy samples may establish the invasive potential of tumours at their initial presentation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16338034     DOI: 10.1016/j.bjoms.2005.10.005

Source DB:  PubMed          Journal:  Br J Oral Maxillofac Surg        ISSN: 0266-4356            Impact factor:   1.651


  18 in total

1.  Tumor and salivary matrix metalloproteinase levels are strong diagnostic markers of oral squamous cell carcinoma.

Authors:  Marni Stott-Miller; John R Houck; Pawadee Lohavanichbutr; Eduardo Méndez; Melissa P Upton; Neal D Futran; Stephen M Schwartz; Chu Chen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-09-29       Impact factor: 4.254

2.  The impact of tumor receptor heterogeneity on the response to anti-angiogenic cancer treatment.

Authors:  Ding Li; Stacey D Finley
Journal:  Integr Biol (Camb)       Date:  2018-04-23       Impact factor: 2.192

Review 3.  Matrix-metalloproteinases as targets for controlled delivery in cancer: An analysis of upregulation and expression.

Authors:  Kyle J Isaacson; M Martin Jensen; Nithya B Subrahmanyam; Hamidreza Ghandehari
Journal:  J Control Release       Date:  2017-01-31       Impact factor: 9.776

4.  May High MMP-2 and TIMP-2 Expressions Increase or Decrease the Aggressivity of Oral Cancer?

Authors:  Bijayatha Shrestha; Dipshikha Bajracharya; Aditi Amit Byatnal; Asha Kamath; Raghu Radhakrishnan
Journal:  Pathol Oncol Res       Date:  2016-11-16       Impact factor: 3.201

5.  Gene Expression Signatures of Lymph Node Metastasis in Oral Cancer: Molecular Characteristics and Clinical Significances.

Authors:  Xiqiang Liu; Antonia Kolokythas; Jianguang Wang; Hongzhang Huang; Xiaofeng Zhou
Journal:  Curr Cancer Ther Rev       Date:  2010-11-01

6.  Osteoactivin regulates head and neck squamous cell carcinoma invasion by modulating matrix metalloproteases.

Authors:  Oneida A Arosarena; Eric W Barr; Ryan Thorpe; Hilary Yankey; Joseph T Tarr; Fayez F Safadi
Journal:  J Cell Physiol       Date:  2017-04-25       Impact factor: 6.384

7.  In vitro antioxidative potential of lactoferrin and black tea polyphenols and protective effects in vivo on carcinogen activation, DNA damage, proliferation, invasion, and angiogenesis during experimental oral carcinogenesis.

Authors:  P Vidjaya Letchoumy; K V P Chandra Mohan; J J Stegeman; H V Gelboin; Y Hara; S Nagini
Journal:  Oncol Res       Date:  2008       Impact factor: 5.574

8.  Induction of Proteases in Peritoneal Carcinomatosis, the Role of ICAM-1/CD43 Interaction.

Authors:  Nawar A Alkhamesi; Gretta Roberts; Paul Ziprin; David H Peck
Journal:  Biomark Insights       Date:  2007-10-08

Review 9.  Proteolytic and non-proteolytic roles of membrane type-1 matrix metalloproteinase in malignancy.

Authors:  Alex Y Strongin
Journal:  Biochim Biophys Acta       Date:  2009-05-04

10.  Timp-2 binding with cellular MT1-MMP stimulates invasion-promoting MEK/ERK signaling in cancer cells.

Authors:  Nor Eddine Sounni; Dmitri V Rozanov; Albert G Remacle; Vladislav S Golubkov; Agnes Noel; Alex Y Strongin
Journal:  Int J Cancer       Date:  2010-03-01       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.